Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-11-12-Speech-4-146"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-11-12"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote (continuation)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20091112.17.4-146"2
lpv:hasSubsequent	lp_eu:2009-11-12-Speech-4-1472
lpv:speaker	lp:Sylvie Guillaume2
lpv:spokenAs	member; LIBE (2009-07-16--2012-01-18)3 substitute; AFCO (2009-07-16--2012-01-18)3 substitute; FEMM (2009-07-16--2012-01-18)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-17--2014-06-30)3 member; S&D (2009-07-14--2012-01-18)3 unknown; Parti socialiste (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Mexico Joint Parliamentary Committee (2009-09-16--2014-06-30)3
lpv:translated text	"Neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease are a major factor in long-term disability. They affect more than seven million Europeans, a figure that will probably double in the coming decades as a result of our ageing population. That is why I support the Europe-wide implementation of any system that will enable us to do more to treat the effects of neurodegenerative diseases, in particular, of Alzheimer’s disease and Parkinson’s disease, both at a social level and at a public health level. Indeed, there is currently no treatment to cure neurodegenerative diseases, and yet this is one of Europe’s biggest challenges in the mental health field, which we must tackle with the resources most suitable for the job."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph